CONTINUOUS HAEMODIAFILTRATION side effect
What is CONTINUOUS HAEMODIAFILTRATION ?Drugs associated with CONTINUOUS HAEMODIAFILTRATION
BISOPROLOL BUSULFAN BYETTA CLOFARABINE CYTARABINE DACTINOMYCIN FLUCONAZOLE GEMZAR GLYBURIDE LANSOPRAZOLE MABTHERA METFORMIN METHOTREXATE PEPCID PREDNISOLONE PROGRAF RENAGEL SIMULECT TACROLIMUS TEGRETOL VELCADE VERAPAMIL ZONISAMIDECONTINUOUS HAEMODIAFILTRATION : Bisoprolol Side Effects Report #5679866-3
Consumer or non-health professional from JAPAN reported BISOPROLOL FUMARATE problem on Mar 19, 2008. Male patient, 39 years of age, was treated with BISOPROLOL FUMARATE. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, pleural effusion, pulmonary congestion, renal failure, shock, . BISOPROLOL FUMARATE dosage: 150 MG (150 MG, 1 IN 1 D) ORAL. During the same period patient was treated with AMLODIPINE. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Tegretol Side Effects Report #5630010-8
TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on Feb 07, 2008. Male patient was diagnosed with epilepsy, partial seizures and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, hyperammonaemia, metabolic acidosis, . TEGRETOL dosage: unknown. During the same period patient was treated with VALPROATE, CLONAZEPAM, PHENOBARBITAL, CARZINOPHILIN. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Metformin Side Effects Report #5633941-8
Consumer or non-health professional from GERMANY reported METFORMIN problem on Feb 03, 2008. Female patient, 74 years of age, was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, diabetic nephropathy, haemodialysis, lactic acidosis, renal failure acute, shock, . METFORMIN dosage: unknown. Patient was hospitalized. Patient died.
CONTINUOUS HAEMODIAFILTRATION : Metformin Side Effects Report #5635757-5
METFORMIN problem was reported by a Consumer or non-health professional from GERMANY on Feb 03, 2008. Male patient, 74 years of age, was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, lactic acidosis, multi-organ failure, renal failure acute, shock, . METFORMIN dosage: unknown. Patient was hospitalized. Patient died.
CONTINUOUS HAEMODIAFILTRATION : Mabthera Side Effects Report #5582967-1
Physician from UNITED KINGDOM reported MABTHERA problem on Dec 05, 2007. Male patient, 65 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with MABTHERA. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, encephalopathy, hepatitis b, . MABTHERA dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOXORUBICIN, VINCRISTINE, PREDNISOLONE. Patient was hospitalized. Patient died on 05/05/2007.
CONTINUOUS HAEMODIAFILTRATION : Tegretol Side Effects Report #5513748-2
TEGRETOL problem was reported by a Consumer or non-health professional from JAPAN on Nov 05, 2007. Male patient was diagnosed with partial seizures and was treated with TEGRETOL. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, hyperammonaemia, metabolic acidosis, . TEGRETOL dosage: unknown. During the same period patient was treated with VALPROATE, CLONAZEPAM, PHENOBARBITAL, CARZINOPHILIN. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Dactinomycin Side Effects Report #5485297-1
Pharmacist from UNITED STATES reported DACTINOMYCIN problem on Oct 10, 2007. Male patient, weighting 30.42 lb, was diagnosed with nephroblastoma and was treated with DACTINOMYCIN. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, venoocclusive liver disease, . DACTINOMYCIN dosage: 0.6 MG - 0.045 MG/KG EVERY 3 WEEKS IV. During the same period patient was treated with VINCRISTINE, ONDANSETRON, MIRALAX, BACTRIM, NIFEREX, CEPHALEXIN. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Renagel Side Effects Report #5416508-6
RENAGEL problem was reported by a Physician from JAPAN on July 31, 2007. Female patient, 72 years of age, weighting 78.26 lb, was diagnosed with hyperphosphataemia, hyperkalaemia and was treated with RENAGEL. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, diverticulum, haemodialysis, large intestine perforation, . RENAGEL dosage: unknown. During the same period patient was treated with CALCIUM POLYSTYRENE SULFONATE, AMLODIPINE BESYLATE, ENALAPRIL MALEATE, CARVEDILOL, BLOPRESS, SPIRONOLACTONE, ASPIRIN, ALLOPURINOL. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Pepcid Side Effects Report #5440821-X
Physician from JAPAN reported PEPCID RPD problem on Aug 29, 2007. Male patient, 56 years of age, was treated with PEPCID RPD. After drug was administered, patient experienced the following problems/side effects: continuous haemodiafiltration, hepatic atrophy, hepatic encephalopathy, hepatitis fulminant, liver transplant, no therapeutic response, . PEPCID RPD dosage: unknown. During the same period patient was treated with PERSANTINE, RYTHMODAN, CANDESARTAN CILEXETIL, WARFARIN. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Methotrexate Side Effects Report #5677604-1
METHOTREXATE problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Mar 04, 2008. Female patient, 60 years of age, weighting 176.4 lb, was treated with METHOTREXATE. After drug was administered, patient experienced the following problems/side effects: beta haemolytic streptococcal infection, continuous haemodiafiltration, multi-organ failure, sepsis, . METHOTREXATE dosage: 7.5 MG WEEKLY. During the same period patient was treated with ENBREL, PREDNISOLONE, ASPIRIN, ATENOLOL, FUROSEMIDE, GLICLAZIDE, MELOXICAM, OMEPRAZOLE. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Simulect Side Effects Report #5624212-4
Consumer or non-health professional from JAPAN reported SIMULECT problem on Feb 06, 2008. Male patient, 56 years of age, was diagnosed with renal transplant and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, continuous haemodiafiltration, hypersensitivity, hypotension, kidney transplant rejection, respiratory disorder, urine output decreased, . SIMULECT dosage: 20 MG, ONCE/SINGLE. During the same period patient was treated with CELLCEPT, NEORAL, SANDIMMUNE, PROPOFOL, FENTANYL, VECURONIUM BROMIDE, SEVOFLURANE. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Tacrolimus Side Effects Report #5646324-1
TACROLIMUS problem was reported by a Physician from AUSTRALIA on Feb 11, 2008. Male patient, 47 years of age, was diagnosed with liver transplant and was treated with TACROLIMUS. After drug was administered, patient experienced the following problems/side effects: biliary anastomosis complication, continuous haemodiafiltration, metabolic acidosis, nephrogenic systemic fibrosis, portal vein thrombosis, post procedural complication, renal failure acute, . TACROLIMUS dosage: 7 MG, BID, ORAL. During the same period patient was treated with PREDNISOLONE, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, OMNISCAN. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Zonisamide Side Effects Report #5572353-2
Physician from JAPAN reported ZONISAMIDE problem on Dec 07, 2007. Male patient, 30 years of age, was diagnosed with epilepsy and was treated with ZONISAMIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, continuous haemodiafiltration, disseminated intravascular coagulation, faecal incontinence, feeding disorder, heat stroke, malaise, multi-organ failure, renal failure, . ZONISAMIDE dosage: 400 MG, ORAL. Patient was hospitalized and became disabled. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Simulect Side Effects Report #5506157-3
SIMULECT problem was reported by a Consumer or non-health professional from JAPAN on Oct 29, 2007. Male patient, 56 years of age, was diagnosed with renal transplant, induction of anaesthesia and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, continuous haemodiafiltration, hypersensitivity, hypotension, respiratory disorder, . SIMULECT dosage: unknown. During the same period patient was treated with PROPOFOL, FENTANYL, VECURONIUM BROMIDE, SEVOFLURANE, OXYGEN, ANESTHETICS NOS. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Simulect Side Effects Report #5518962-8
Consumer or non-health professional from JAPAN reported SIMULECT problem on Nov 08, 2007. Male patient, 56 years of age, was diagnosed with renal transplant and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, continuous haemodiafiltration, hypersensitivity, hypotension, kidney transplant rejection, respiratory disorder, urine output decreased, . SIMULECT dosage: 20 MG, ONCE/SINGLE. During the same period patient was treated with CELLCEPT, NEORAL, SANDIMMUNE, PROPOFOL, FENTANYL, VECURONIUM BROMIDE, SEVOFLURANE. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Simulect Side Effects Report #5519038-6
SIMULECT problem was reported by a Consumer or non-health professional from JAPAN on Nov 08, 2007. Male patient, 56 years of age, was diagnosed with renal transplant, induction of anaesthesia and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, continuous haemodiafiltration, hypersensitivity, hypotension, respiratory disorder, . SIMULECT dosage: unknown. During the same period patient was treated with PROPOFOL, FENTANYL, VECURONIUM BROMIDE, SEVOFLURANE, OXYGEN, ANESTHETICS NOS. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Simulect Side Effects Report #5524832-1
Physician from JAPAN reported SIMULECT problem on Nov 19, 2007. Male patient, 56 years of age, was diagnosed with renal transplant and was treated with SIMULECT. After drug was administered, patient experienced the following problems/side effects: anaphylactic shock, continuous haemodiafiltration, hypersensitivity, hypotension, kidney transplant rejection, respiratory disorder, urine output decreased, . SIMULECT dosage: 20 MG, ONCE/SINGLE. During the same period patient was treated with CELLCEPT, NEORAL, SANDIMMUNE, PROPOFOL, FENTANYL, VECURONIUM BROMIDE, SEVOFLURANE. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Busulfan Side Effects Report #5528069-1
BUSULFAN problem was reported by a Health Professional from JAPAN on Nov 09, 2007. Female patient, child .7 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: ascites, continuous haemodiafiltration, dyspnoea, gallbladder enlargement, haematemesis, hepatic failure, hepatomegaly, hypopnoea, multi-organ failure, . BUSULFAN dosage: 6.6 MG;QID;IV. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Prednisolone Side Effects Report #5413356-8
Consumer or non-health professional from UNITED KINGDOM reported PREDNISOLONE problem on July 25, 2007. Male patient, 42 years of age, was diagnosed with crohn's disease, hepatic haematoma and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: acute abdomen, continuous haemodiafiltration, device migration, haemodynamic instability, hepatic haematoma, intra-abdominal haematoma, oliguria, procedural complication, thrombosis in device, . PREDNISOLONE dosage: unknown. During the same period patient was treated with HAEMOFILTRATION, WARFARIN. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Cytarabine Side Effects Report #5419187-7
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 15, 2007. Female patient, weighting 196.2 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: blood bilirubin increased, continuous haemodiafiltration, hypotension, multi-organ failure, pneumonia, renal tubular necrosis, respiratory distress, respiratory failure, sepsis, . CYTARABINE dosage: 1013.55 MG. During the same period patient was treated with DAUNORUBICIN, ETOPOSIDE. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Gemzar Side Effects Report #5430548-2
Physician from JAPAN reported GEMZAR problem on Aug 27, 2007. Female patient, 53 years of age, was diagnosed with lung adenocarcinoma stage ii and was treated with GEMZAR. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, continuous haemodiafiltration, diffuse alveolar damage, gastrointestinal haemorrhage, hepatic failure, interstitial lung disease, lung infiltration, multi-organ failure, . GEMZAR dosage: unknown. Patient was hospitalized. Patient died on 08/23/2006.
CONTINUOUS HAEMODIAFILTRATION : Metformin Side Effects Report #5679749-9
METFORMIN HYDROCHLORIDE problem was reported by a Consumer or non-health professional from GERMANY on Mar 10, 2008. Male patient, 74 years of age, was treated with METFORMIN HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: cardiogenic shock, concomitant disease aggravated, continuous haemodiafiltration, diabetic nephropathy, dyspnoea, lactic acidosis, multi-organ failure, renal failure acute, . METFORMIN HYDROCHLORIDE dosage: unknown. Patient was hospitalized. Patient died.
CONTINUOUS HAEMODIAFILTRATION : Metformin Side Effects Report #5635761-7
Consumer or non-health professional from GERMANY reported METFORMIN problem on Feb 03, 2008. Female patient, 74 years of age, was treated with METFORMIN. After drug was administered, patient experienced the following problems/side effects: anuria, condition aggravated, continuous haemodiafiltration, diabetic nephropathy, lactic acidosis, renal failure acute, shock, . METFORMIN dosage: unknown. Patient was hospitalized. Patient died.
CONTINUOUS HAEMODIAFILTRATION : Byetta Side Effects Report #5581487-8
BYETTA problem was reported by a Pharmacist from UNITED STATES on Jan 03, 2008. Female patient, 55 years of age, weighting 218.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: bradycardia, cardiac arrest, continuous haemodiafiltration, dyspnoea, fat necrosis, fatigue, hypotension, metabolic acidosis, multi-organ failure, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN, GLIPIZIDE, LISINOPRIL. Patient was hospitalized. Patient died on 10/31/2007.
CONTINUOUS HAEMODIAFILTRATION : Glyburide Side Effects Report #5590857-3
Consumer or non-health professional from SPAIN reported GLYBURIDE problem on Dec 26, 2007. Female patient, 61 years of age, was diagnosed with diabetes mellitus and was treated with GLYBURIDE. After drug was administered, patient experienced the following problems/side effects: acute prerenal failure, blood glucose increased, continuous haemodiafiltration, dehydration, food intolerance, haemodialysis, hypotension, kussmaul respiration, lactic acidosis, . GLYBURIDE dosage: 5 MG TWICE DAILY. During the same period patient was treated with METFORMIN, LOVASTATIN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Busulfan Side Effects Report #5608393-4
BUSULFAN problem was reported by a Consumer or non-health professional from JAPAN on Jan 11, 2008. Male patient, child 7 years of age, was diagnosed with stem cell transplant and was treated with BUSULFAN. After drug was administered, patient experienced the following problems/side effects: anorexia, coagulopathy, continuous haemodiafiltration, febrile neutropenia, gastritis, haemosiderosis, hepatic function abnormal, hyperbilirubinaemia, hypoproteinaemia, . BUSULFAN dosage: 6 ML; IV. Patient was hospitalized. Patient died on 11/29/2007.
CONTINUOUS HAEMODIAFILTRATION : Prograf Side Effects Report #5535082-7
Physician from JAPAN reported PROGRAF problem on Nov 15, 2007. Male patient, 67 years of age, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: back pain, biliary tract disorder, continuous haemodiafiltration, hepatic fibrosis, hepatitis b, hepatitis cholestatic, hyperplasia, pancreatitis acute, . PROGRAF dosage: unknown. During the same period patient was treated with STEROIDMULATION. Patient died.
CONTINUOUS HAEMODIAFILTRATION : Clofarabine Side Effects Report #5527535-2
CLOFARABINE problem was reported by a Health Professional from UNITED STATES on Nov 08, 2007. Female patient, 15 years of age, weighting 207.9 lb, was diagnosed with acute lymphocytic leukaemia and was treated with CLOFARABINE. After drug was administered, patient experienced the following problems/side effects: acidosis, capillary leak syndrome, continuous haemodiafiltration, febrile neutropenia, haematocrit decreased, haemoglobin decreased, hepatosplenomegaly, hypotension, hypoxia, . CLOFARABINE dosage: 80 MG QD IV. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE, ACETAMINOPHEN, ACYCLOVIR, ALLOPURINOL, AMIKACIN, CALCITRIOL, CHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Zonisamide Side Effects Report #5531699-4
Physician from JAPAN reported ZONISAMIDE problem on Nov 14, 2007. Male patient, 30 years of age, was diagnosed with epilepsy and was treated with ZONISAMIDE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, brain stem syndrome, continuous haemodiafiltration, disseminated intravascular coagulation, faecal incontinence, feeding disorder, heat stroke, malaise, multi-organ failure, . ZONISAMIDE dosage: 400 MG, ORAL. Patient was hospitalized and became disabled. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Verapamil Side Effects Report #5491436-9
VERAPAMIL HYDROCHLORIDE problem was reported by a Health Professional from FRANCE on Oct 05, 2007. Male patient, 51 years of age, was diagnosed with hypertensive cardiomyopathy and was treated with VERAPAMIL HYDROCHLORIDE. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, atrioventricular block complete, continuous haemodiafiltration, metabolic acidosis, multi-organ failure, renal failure, shock, . VERAPAMIL HYDROCHLORIDE dosage: 7200 MG;X1. Patient died.
CONTINUOUS HAEMODIAFILTRATION : Lansoprazole Side Effects Report #5450974-5
Consumer or non-health professional from JAPAN reported LANSOPRAZOLE problem on Sept 04, 2007. Male patient, 71 years of age, was diagnosed with gastric ulcer, reflux oesophagitis and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: altered state of consciousness, condition aggravated, continuous haemodiafiltration, electroencephalogram abnormal, hepatic encephalopathy, hepatic failure, hyperammonaemia, hypoglycaemia, renal failure, . LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with ITOROL, CARVEDILOL, MUCOSTA, FOIPAN, SIGMART, ALLOPURINOL, LASIX. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Fluconazole Side Effects Report #5420599-6
FLUCONAZOLE problem was reported by a Consumer or non-health professional from FINLAND on July 20, 2007. Male patient, 76 years of age, was diagnosed with graft infection, hyperlipidaemia and was treated with FLUCONAZOLE. After drug was administered, patient experienced the following problems/side effects: anuria, cardiomegaly, continuous haemodiafiltration, dyspnoea, haemoglobin decreased, hypotension, international normalised ratio increased, multi-organ failure, . FLUCONAZOLE dosage: 150 MG (150 MG, 1 IN 1 D). During the same period patient was treated with ATORVASTATIN CALCIUM, ESOMEPRAZOLE, FUSIDIC ACID, DOXYCYCLINE, PREDNISOLONE, WARFARIN, DIGOXIN, BISOPROLOL FUMARATE. Patient was hospitalized. Patient died.
CONTINUOUS HAEMODIAFILTRATION : Velcade Side Effects Report #5391777-X
Physician from GERMANY reported VELCADE problem on July 06, 2007. Male patient, 53 years of age, weighting 220.5 lb, was diagnosed with plasmacytoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cardiac failure, continuous haemodiafiltration, disseminated intravascular coagulation, heart rate increased, hepatic failure, multi-organ failure, pulmonary embolism, renal failure acute, . VELCADE dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, DIPYRONE, BUPRENORPHINE HYDROCHLORIDE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.
CONTINUOUS HAEMODIAFILTRATION : Velcade Side Effects Report #5391777-X
VELCADE problem was reported by a Physician from GERMANY on July 06, 2007. Male patient, 53 years of age, weighting 220.5 lb, was diagnosed with plasmacytoma and was treated with VELCADE. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, cardiac failure, continuous haemodiafiltration, disseminated intravascular coagulation, heart rate increased, hepatic failure, multi-organ failure, pulmonary embolism, renal failure acute, . VELCADE dosage: 2.60 MG, INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DEXAMETHASONE, DIPYRONE, BUPRENORPHINE HYDROCHLORIDE, PANTOPRAZOLE. Patient was hospitalized. Patient recovered.